TRADING HALTED

Celgene Corp CELG:Swiss Exchange

*Data is delayed | CHF
Last | 06/28/19 CEST
89.40UNCH (UNCH)
52 week range
89.40 - 97.56

...

Loading . . .
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close89.40
  • 52 Week High97.56
  • 52 Week High Date06/24/19
  • 52 Week Low89.40
  • 52 Week Low Date06/28/19

Key Stats

  • Market Cap
  • Shares Out
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close89.40
  • 52 Week High97.56
  • 52 Week High Date06/24/19
  • 52 Week Low89.40
  • 52 Week Low Date06/28/19
  • Market Cap
  • Shares Out
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)8.00
  • P/E (TTM)11.18
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Celgene Corp

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Celgene Corporation is an integrated global biopharmaceutical company. The Company, together with its subsidiaries, is engaged in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases through solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation. Its commercial-stage products include REVLIMID (lenalidomide), POMALYST/IMNOVID (pomalidomide), OTEZLA (apremilast), ABRAXANE...
Address
86 Morris Ave
Summit, NJ
07901-3915
United States